MERS-CoV: presumptive positive sample referral pathway
- Public Health England
- Part of:
- Middle East respiratory syndrome coronavirus (MERS-CoV): clinical management and guidance
- 26 August 2014
- Last updated:
- 30 June 2017, see all updates
How to refer presumptive positive Middle East respiratory syndrome coronavirus (MERS-CoV) samples to the National Reference Laboratory.
Referral of presumptive positive Middle East respiratory syndrome coronavirus (MERS-CoV) samples to the National Reference Laboratory
Ref: PHE publications gateway number 2017154 PDF, 63.6KB, 7 pages
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email firstname.lastname@example.org. Please tell us what format you need. It will help us if you say what assistive technology you use.
This document provides advice for diagnostic laboratories on:
- primary testing and confirmatory testing arrangements for MERS-CoV in England
- how to request confirmatory testing and how to send samples to the Respiratory Virus Unit
- required public health actions
- actions to take for non-MERS coronavirus results
- referral of further specimens from confirmed MERS cases
- recommendations for non-PHE clinical diagnostic laboratories considering provision of MERS-CoV testing in England
Published: 26 August 2014
Updated: 30 June 2017
- Updated document.
- Updated with August 2016 publication.
- Added 2 labs to the referral pathway: Leeds and Manchester.
- Updated to include Edinburgh on the list of PHE public health laboratory and the devolved administration laboratories.
- Updated version (April 2015) of referral pathway.
- First published.